Article
Response to treatment with interferon-alpha and ribavirin in patients with chronic Hepatitis C virus genotypes 2 and 3 depends on the degree of hepatic fibrosis.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases - 1 Apr 2006
Parise Edison Roberto, de Oliveira Ana Cláudia, Conceição Raquel D O, Amaral Ana Cristina, Leite Katia
Abstract excerpt
The combined therapy with interferon alfa plus ribavirin (INF+RBV) is considered the most appropriate treatment for patients with chronic hepatitis C virus genotypes 2 and 3 in Brazil. However, wide variations in the rates of sustained viral response (SVR) have been reported among such patients. We evaluated, retrospectively, factors associated with SVR in subjects with chronic hepatitis C virus genotypes 2 and 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
